Job title : Medical Science Liaison Location : Brasilia – São Paulo About the job We never settle and now we are creating a new paradigm with a first‑in‑class therapy in Autoimmune Diabetes (Type 1 Diabetes). Our newest core asset, resulting from the acquisition of Provention Bio in General Medicines Autoimmune Type 1 Diabetes space, aims at delaying the onset of stage 3 type 1 diabetes. This means that for the first time, people at risk of developing this lifelong disease have fresh hope. What delayed onset means is more time for children to be children with less healthcare and more care‑free childhood. The delay also gives families and healthcare professionals more time to prepare care plans for a later diagnosis. Main responsibilities Scientific Leadership & KOL Engagement Act as trusted scientific partner to external experts (KOLs, endocrinologists, pediatricians) Conduct scientific exchange on T1D disease stages, screening importance, and treatment approaches Share scientific data...